백서 패혈증 모델에서 HSP70의 과도 발현이 iNOS의 발현에 미치는 효과에 관한 연구

키워드

참고문헌 (46)

1. Dong HP, "Previous heat shock treatment attenuates lipopolysaccharide-induced hyporesponsiveness of platelets in rats", Shock, 24, pp.239~244 (2005)
2. Angus DC, "Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care", Crit Care Med, 29, pp.1303~1310 (2001)
3. Augus DC, "Epidemiology of sepsis: an update", Crit Care Med, 29(7), pp.109~116 (2001)
4. O’Brien JM Jr, "New approaches to the treatment of sepsis", Clin Chest Med, 24, pp.521~548 (2003)
5. Dellinger RP, "Cardiovascular management of septic shock", Crit Care Med, 31, pp.946~955 (2003)
6. Holmes CL, "Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy", Chest, 124, pp.1103~1115 (2003)
7. Chen HW, "Heat shock pretreatment prevents cardiac mitochondrial dysfunction during sepsis", Shock, 20, pp.274~279 (2003)
8. Pinsky MR, "Dysregulation of the immune response in severe sepsis", Am J Med Sci, 328, pp.220~229 (2004)
9. Cohen RI, "Nitric oxide modifies the sarcoplasmic reticular calcium release channel in endotoxemia by both guanosine-3’, 5’(cyclic) phosphate-dependent and independent pathways", Crit Care Med, 34, pp.173~181 (2006)
10. Cariou A, "Adjunctive therapies in sepsis: an evidence-based review", Crit Care Med, 32(11), pp.562~570 (2004)
11. Opal SM, "Endotoxin as a drug target", Crit Care Med, 31(1), pp.57~64 (2003)
12. Opal SM, "Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebocontrolled, multicenter trial. The Interleukin-1 Receptor Aantagonist Sepsis Investigator Group", Crit Care Med, 25, pp.1115~1124 (1997)
13. Wenzel RP, "Treating sepsis", N Engl J Med, 347, pp.966~967 (2002)
14. Wheeler AP, "Treating patients with severe sepsis", N Engl J Med, 340, pp.207~214 (1999)
15. Annane D, "Effect of treatment with low doses of hydrocortisone and fluorocortisone on mortality in patients with septic shock", JAMA, 288, pp.862~871 (2002)
16. Bernard GR, "Efficacy and safety of recombinant human activated protein C for severe sepsis", N Engl J Med, 344, pp.699~709 (2001)
17. Corrigan JJ Jr, "Heparin therapy in bacterial septicemia", J Pediatr, 91, pp.695~700 (1977)
18. Abraham E, "Double-blind randomized controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group", Lancet, 351, pp.929~933 (1998)
19. Cole L, "A phase II randomized, controlled trial of continuous hemofiltration in sepsis", Crit Care Med, 30, pp.100~106 (2002)
20. Sander A, "Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but dose not alter IL-6 and TNF-α plasma concentrations", Intensive Care Med, 23, pp.878~884 (1997)
21. Kellum JA, "Diffusive vs. convective therapy: effects on mediators of inflammation in patients with severe systemic inflammatory response syndrome", Crit Care Med, 26, pp.1995~2000 (1998)
22. Braun N, "Effects of continuous hemodiafiltration on IL-6, TNFalpha, C3a and TCC in patients with SIRS", septic shock using two different membranes, 1995, pp.116, 89~98
23. McMaster P, "The use of extracorporeal techniques to remove humoral factors in sepsis", ediatric Crit Care Med, 4, pp.2~7 (2003)
24. Dellinger RP, "Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock", Crit Care Med, 32, pp.858~873 (2004)
25. Rivers E, "Early goal-directed therapy in the treatment of severe sepsis and septic shock", N Engl J Med, 345, pp.1368~1377 (2001)
26. Rhodes A, "Early-goal directed therapy: an evidencebased review", Crit Care Med, 32(11), pp.448~450 (2004)
27. Thiemermann C, "Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide", Proc Natl Acad Sci U S A, 90, pp.267~271 (1993)
28. Aranow JS, "A selective inhibitor of inducible in nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: comparison with two nonselective strategies", Shock, 5, pp.116~121 (1996)
29. Grover R, "An open-label dose escalation study of the nitric oxide synthase inhibitor NG-methyl-arginine hydrochloride (546C88) in patients with septic shock", Crit Care Med, 27, pp.913~922 (1999)
30. Watson D, "Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)", Crit Care Med, 32, pp.13~20 (2004)
31. Ritossa FA, "A new puffing pattern induced by temperature shock and DNP in Drosophillia", Experientia, 18, pp.571~573 (1962)
32. Tandara AA, "Age effect on HSP70: decreased resistance to ischemic and oxidative stress in HDF", J Surg Res, 132, pp.32~39 (2006)
33. Sigal LH, "Molecular biology and immunology for clinicians 18: Heat shock proteins", chaperonins, 2002, pp.8, 174~180
34. Li PL, "Potentiation of baroreceptor reflex response by heat shock protein 70 in nucleus tractus solitarii confers cardiovascular protection during heatstroke", Circulation, 103, pp.2114~2119 (2001)
35. Yang RC, "Previous heat shock treatment attenuates bicuculline-induced convulsions in rats", Exp Brain Res, 108, pp.18~22 (1996)
36. Nakada J, "Oral administration of geranylgeranylacetone improves survival rate in a rat endotoxin shock model: administration timing and heat shock protein 70 induction", Shock, 24, pp.482~487 (2005)
37. Masuda Y, "Geranylgeranylacetone attenuates septic diaphragm dysfunction by induction of heat shock protein 70", rit Care Med, 31, pp.2585~2591 (2003)
38. Yang SL, "The effect of hyperthermic treatment on electroencephalographic recovery after interruption of respiration in rats", Exp Brain Res, 99, pp.431~434 (1994)
39. Kiang JG, "Inducible heat shock protein 70 kD and inducible nitric oxide synthase in hemorrhage", resuscitation-induced injury, 2004, pp.14, 450~459
40. Sumioka I, "Potential roles of hepatic heat shock protein 25 and 70i in protection of mice against acetaminophen-induced liver injury", Life Sci, 74, pp.2551~2561 (2004)
41. Su F, "Fever control in septic shock: beneficial or harmful?", Shock, 23, pp.516~520 (2005)
42. Singleton KD, "Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression", Crit Care Med, 33, pp.1206~1213 (2005)
43. Sanli A, "Glutamine administration enhances the healing of lung parenchymal injuries and reduces air leakage in rats", Tohoku J Exp Med, 210, pp.239~245 (2006)
44. Doruk N, "Oral The effect of preventive use of alanyl-glutamine on diaphragm muscle function in cecal ligation and puncture-induced sepsis model", JPEN J Parenter Enteral Nutr, 29, pp.36~43 (2005)
45. Kim DJ, "Comparison of experimental lung injury from acute renal failure with injury due to sepsis", Respiration, 73, pp.815~824 (2006)
46. Torres-Duen ̃as D, "Failure of neutrophil migration to infectious focus and cardiovascular changes on sepsis in rats: effects of the inhibition of nitric oxides production, removal of infectious focus, and antimicrobial treatment", Shock, 25, pp.267~276 (2006)

관련 논문AI추천